-
-
-
-
-
Original Sequence
- TLKQFAKGVGKWLVK
-
Source
- Synthetic construct
-
-
Biological Activity
- Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-
-
- Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.
-
Target Organism
-
- [Ref.24211019] Gram-positive bacteria: Bacillus subtilis (MIC = 6.25 μg/mL), Staphylococcus aureus (MIC = 6.25 μg/mL), Staphylococcus epidermis (MIC > 200 μg/mL);
- Gram-negative bacteria: Escherichia coli (MIC = 100 μg/mL), Shigella dysentariae (MIC = 50 μg/mL), Salmonella typhimurium (MIC > 200 μg/mL), Klebsiella pneumonia (MIC = 50 μg/mL), Proteus mirabilis (MIC > 200 μg/mL), Pseudomonas aeuginose (MIC = 200 μg/mL).
-
Hemolytic Activity
-
- [Ref.24211019] No hemolytic activity information found.
-
Cytotoxicity
-
No cytotoxicity information found in the reference(s) presented
-
Linear/Cyclic
- Cyclic (Stapled)
-
N-terminal Modification
- Acetylation
-
C-terminal Modification
- Amidation
-
Special Amino Acid and Stapling Position
- ①The Ⓧ (position: 6 and 10) in sequence indicates (S)-α-methyl, α-pentenylglycine. ②Ⓧ (6) and Ⓧ (10) are cross-linked by hydrocarbon stapling through an oct-4-enyl staple.
-
-
Secondary Structure
- 27% α-helical content in a 25 mM potassium phosphate buffer solution at 20 ℃.
-
Structure Description
- ①On the other hand, all three stapled analogs of E2EM15W showed substantial increases in helical contents, which again demonstrated the highly effective helix-stabilization through the all-hydrocarbon stapling technology. ②Although they bear the oce-4-enyl staple at the same positions as in E2EM15W-S1, the other stapled derivatives E2EM15W-S2 and E2EM15W-S3 exhibited markedly smaller helical contents: 27% and 37%, repectively.
-
- Literature 1
-
Title
- Truncated and constrained helical analogs of antimicrobial esculentin-2EM
-
-
Reference
- Bioorg Med Chem Lett. 2013 Dec 15;23(24):6717-20. doi: 10.1016/j.bmcl.2013.10.031. Epub 2013 Oct 26.
-
Author
- Thanh Kim Pham, Do-Hee Kim, Bong-Jin Lee, Young-Woo Kim